This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
| Assets | Price ($) |
Return 12m |
DY |
P/E |
P/BV |
ROE |
Net Profit Margins |
|---|---|---|---|---|---|---|---|
|
IMMP
Immutep Limited
Immutep Limited
|
$3.25 | -92.15% | 0.00% | 0.00 | 0.00 | 0.00% | 0.00% |
PFE
Pfizer Inc.
Pfizer Inc.
|
$29.30 | 29.93% | 5.91% | 38.29 | 1.94 | 5.07% | 6.80% |
ABBV
AbbVie Inc.
AbbVie Inc.
|
$283.02 | 27.22% | 2.40% | 79.71 | -84.84 | -106.44% | 9.81% |
NVO
Novo Nordisk A/S
Novo Nordisk A/S
|
$38.44 | -25.78% | 4.74% | 9.57 | 5.08 | 53.11% | 35.32% |
MRK
Merck & Co. Inc.
Merck & Co. Inc.
|
$144.69 | 75.65% | 2.34% | 113.15 | 8.55 | 7.56% | 4.77% |
AZN
AstraZeneca PLC
AstraZeneca PLC
|
$165.06 | -0.87% | 1.95% | 19.76 | 5.09 | 25.77% | 16.95% |
BMY
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
|
$58.66 | 42.28% | 4.19% | 13.18 | 5.48 | 41.59% | 18.87% |
ZTS
Zoetis Inc.
Zoetis Inc.
|
$79.45 | -43.79% | 2.64% | 12.52 | 10.49 | 83.77% | 27.69% |
AMGN
Amgen Inc.
Amgen Inc.
|
$426.52 | 46.68% | 2.29% | 26.86 | 20.10 | 74.80% | 22.95% |
REGN
Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
|
$782.52 | 35.91% | 0.47% | 18.88 | 2.58 | 13.65% | 27.86% |
HALO
Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
|
$122.82 | 83.23% | 0.00% | 34.40 | 99.12 | 288.13% | 24.86% |
MCK
McKesson Corporation
McKesson Corporation
|
$994.67 | 27.04% | 0.34% | 25.91 | -30.79 | -118.84% | 1.12% |
VRTX
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
|
$502.58 | 20.58% | 0.00% | 29.00 | 6.31 | 21.76% | 35.00% |
CAH
Cardinal Health Inc.
Cardinal Health Inc.
|
$250.05 | 61.38% | 0.81% | 34.89 | -21.95 | -62.92% | 0.67% |
ARGX
argenx SE
argenx SE
|
$820.58 | -2.74% | 0.00% | 13.83 | 3.67 | 26.52% | 25.54% |
HRMY
Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc.
|
$37.50 | 44.79% | 0.00% | 12.22 | 2.22 | 18.14% | 18.88% |
BIIB
Biogen Inc.
Biogen Inc.
|
$232.87 | 62.85% | 0.00% | 41.65 | 1.84 | 4.43% | 8.32% |
Current Dividend Yield
0.00%
5-year average Dividend Yield
0.00%
Current Payout
—
5-year average Payout
—
Average Investor10 user rating
4.0
(1 people)
Founded: 2001
Time since IPO - 14 years
Employees
Immutep Limited (United States) is listed on the Nasdaq and has a market capitalization of $474.81 million, with shareholders equity totaling $-.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Immutep Limited reported $- in revenue, generating net income of $-.
Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IMMP.
Market cap
$474.81 million
$474.81 million
Net worth
$-
$-
Assets
$-
$-
Total Shares Outstanding
147.00 million
147,000,000
Average Daily Trading Volume
$17.20 Thousand
$17,195.32
Shares
0.00
0.00%
-893.55%
0.00
25.91
0.34%
-118.84%
-30.79
34.89
0.81%
-62.92%
-21.95
79.71
2.40%
-106.44%
-84.84
113.15
2.34%
7.56%
8.55
19.76
1.95%
25.77%
5.09
38.29
5.91%
5.07%
1.94
13.18
4.19%
41.59%
5.48
0.00
0.00%
-893.55%
0.00
25.91
0.34%
-118.84%
-30.79
34.89
0.81%
-62.92%
-21.95
79.71
2.40%
-106.44%
-84.84
113.15
2.34%
7.56%
8.55
19.76
1.95%
25.77%
5.09
38.29
5.91%
5.07%
1.94
13.18
4.19%
41.59%
5.48
The current price of Immutep (IMMP) is $3.25. The stock began the year trading around $2.86 and is currently priced at $3.25. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.
Immutep (IMMP) did not pay dividends over the past year.
Immutep (IMMP) is currently trading at $3.25 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -92.15%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
You can buy Immutep (IMMP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol IMMP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.
Over the past month, Immutep (IMMP) has returned -45.16% — -92.15% over the past year, and -96.22% over the past five years, including price appreciation and dividends.
In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.
If you were to purchase 100 shares of Immutep (IMMP) today at the current price of $3.25 your total investment would be $325.00.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings